Extracorporeal membrane oxygenation (ECMO) is frequently used for severe postcardiotomy cardiogenic shock in patients with bioprosthetic valves. Acute prosthetic valve thrombosis (PVT) is a rare complication after valve replacement surgery and significantly increases morbidity and mortality. Patients who develop PVT on ECMO could significantly influence the long-term durability of the bioprosthetic valves. However, previous studies only analyzed risk factor and treatment of the mitral valve thrombosis during ECMO support. The mechanism of thrombosis on the tricuspid valve was still unknown. Here we describe the symptoms and treatment of a valve replacement patient who developed bioprosthetic tricuspid valve thrombosis during veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Meanwhile, the patient’s mechanical prosthetic mitral valve functioned normally. An emergency re-do tricuspid prosthesis replacement was performed, and the patient finally developed the successful decannulation. At 6 months follow-up, the patient showed asymptomatic and had a reasonable quality of life. The pathophysiology of tricuspid valve thrombosis may be different from the left heart. Our case highlights that the risk of thrombosis associated with a prosthesis in the tricuspid position can be even higher in the setting of VA-ECMO support. In such patients, promoting forward blood flow across the prosthesis and improving levels of anticoagulation may be particularly important.
| Published in | International Journal of Anesthesia and Clinical Medicine (Volume 12, Issue 1) |
| DOI | 10.11648/j.ijacm.20241201.13 |
| Page(s) | 11-14 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Prosthetic Valve Thrombosis, Extracorporeal Membrane Oxygenation, Bioprosthetic Tricuspid Valve, Case Report
| [1] | Wang JG, Han J, Jia YX, Zeng W, Hou XT, Meng X. Outcome of veno-arterial extracorporeal membrane oxygenation for patients undergoing valvular surgery. PLoS One. 2013; 8(5): e63924. Published 2013 May 23. https://doi.org/10.1371/journal.pone.0063924 |
| [2] | Alhijab FA, Tantawy TM, Ismail HH, et al. Venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock: The impact of cannulation strategy on survival. Perfusion. 2023; 38(7): 1444-1452. https://doi.org/10.1177/02676591221114954 |
| [3] | Arafat AA, AlBarrak M, Kiddo M, et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock after valve replacement. Perfusion. Published online January 16, 2023. https://doi.org/10.1177/02676591231152723 |
| [4] | Groenewoud R, Gunning D, Fava C, Sharpe R, Valchanov K, Shayan H. Successful thrombolysis of early bioprosthetic mitral valve thrombosis following extracorporeal membrane oxygenation: Case report. Perfusion. Published online February 16, 2023. https://doi.org/10.1177/02676591231157200 |
| [5] | Callisen H, Sen A, Lanza L, et al. Management of Acute Mechanical Mitral Valve Thrombosis With Venoarterial Extracorporeal Membrane Oxygenation (ECMO). J Cardiothorac Vasc Anesth. 2017; 31(1): 240-242. https://doi.org/10.1053/j.jvca.2016.05.009 |
| [6] | Tsiouris A, Nemeh H, Borgi J. Early acute thrombosis of bioprosthetic mitral valve presenting with cardiogenic shock. Gen Thorac Cardiovasc Surg. 2013; 61(3): 152-154. https://doi.org/10.1007/s11748-012-0121-4 |
| [7] | Challa A, Latona J, Fraser J, et al. Mitral valve bio-prosthesis and annuloplasty thrombosis during extracorporeal membrane oxygenation: case series. Eur Heart J Case Rep. 2020; 4(3): 1-6. Published 2020 Apr 24. https://doi.org/10.1093/ehjcr/ytaa085 |
| [8] | Dahl AB, Gregory SH, Ursprung E, Kawabori M, Couper GS, Hueneke R. Acute Presentation of Bioprosthetic Mitral Valve Thrombosis in a Patient on Venoarterial Extracorporeal Membranous Oxygenation. J Cardiothorac Vasc Anesth. 2019; 33(3): 844-849. https://doi.org/10.1053/j.jvca.2018.05.007 |
| [9] | Cevasco M, Saha A, Garan A R, et al. Incidence and Outcomes of Prosthetic Valve Thrombosis during Extracorporeal Membrane Oxygenation Support for Postcardiotomy Shock. The Journal of Heart and Lung Transplantation, 2019, 38(4): S423. https://doi.org/10.1016/j.healun.2019.01.1078 |
| [10] | Kagiyama N, Okura H, Nezuo S, et al. Two cases of acute bioprosthetic mitral valve thrombosis immediately after mitral valve replacement. Circulation. 2014; 129(6): e328-e330. https://doi.org/10.1161/CIRCULATIONAHA.113.005583 |
| [11] | Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J. 2017; 63(1): 60-67. https://doi.org/10.1097/MAT.0000000000000475 |
| [12] | Labarrere CA, Dabiri AE, Kassab GS. Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices. Front Bioeng Biotechnol. 2020; 8: 123. Published 2020 Mar 12. https://doi.org/10.3389/fbioe.2020.00123 |
| [13] | Murphy DA, Hockings LE, Andrews RK, et al. Extracorporeal membrane oxygenation-hemostatic complications. Transfus Med Rev. 2015; 29(2): 90-101. https://doi.org/10.1016/j.tmrv.2014.12.001 |
| [14] | Noly PE, Tang PC. Commentary: Venoarterial extracorporeal membrane oxygenation, ventricular dysfunction, and a mitral valve prosthesis: A recipe for valve thrombosis? JTCVS Tech. 2020; 3: 209-210. Published 2020 May 5. https://doi.org/10.1016/j.xjtc.2020.04.022 |
| [15] | Egbe A, Pislaru SV, Ali MA, et al. Early Prosthetic Valve Dysfunction Due to Bioprosthetic Valve Thrombosis: The Role of Echocardiography. JACC Cardiovasc Imaging. 2018; 11(7): 951-958. https://doi.org/10.1016/j.jcmg.2017.06.022 |
APA Style
Zhang, Y., Luo, S. (2024). Thrombosis of Prosthetic Tricuspid Valve During Veno-Arterial Extracorporeal Membrane Oxygenation Support: A Case Report. International Journal of Anesthesia and Clinical Medicine, 12(1), 11-14. https://doi.org/10.11648/j.ijacm.20241201.13
ACS Style
Zhang, Y.; Luo, S. Thrombosis of Prosthetic Tricuspid Valve During Veno-Arterial Extracorporeal Membrane Oxygenation Support: A Case Report. Int. J. Anesth. Clin. Med. 2024, 12(1), 11-14. doi: 10.11648/j.ijacm.20241201.13
AMA Style
Zhang Y, Luo S. Thrombosis of Prosthetic Tricuspid Valve During Veno-Arterial Extracorporeal Membrane Oxygenation Support: A Case Report. Int J Anesth Clin Med. 2024;12(1):11-14. doi: 10.11648/j.ijacm.20241201.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijacm.20241201.13,
author = {Yunyi Zhang and Shuhua Luo},
title = {Thrombosis of Prosthetic Tricuspid Valve During Veno-Arterial Extracorporeal Membrane Oxygenation Support: A Case Report},
journal = {International Journal of Anesthesia and Clinical Medicine},
volume = {12},
number = {1},
pages = {11-14},
doi = {10.11648/j.ijacm.20241201.13},
url = {https://doi.org/10.11648/j.ijacm.20241201.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijacm.20241201.13},
abstract = {Extracorporeal membrane oxygenation (ECMO) is frequently used for severe postcardiotomy cardiogenic shock in patients with bioprosthetic valves. Acute prosthetic valve thrombosis (PVT) is a rare complication after valve replacement surgery and significantly increases morbidity and mortality. Patients who develop PVT on ECMO could significantly influence the long-term durability of the bioprosthetic valves. However, previous studies only analyzed risk factor and treatment of the mitral valve thrombosis during ECMO support. The mechanism of thrombosis on the tricuspid valve was still unknown. Here we describe the symptoms and treatment of a valve replacement patient who developed bioprosthetic tricuspid valve thrombosis during veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Meanwhile, the patient’s mechanical prosthetic mitral valve functioned normally. An emergency re-do tricuspid prosthesis replacement was performed, and the patient finally developed the successful decannulation. At 6 months follow-up, the patient showed asymptomatic and had a reasonable quality of life. The pathophysiology of tricuspid valve thrombosis may be different from the left heart. Our case highlights that the risk of thrombosis associated with a prosthesis in the tricuspid position can be even higher in the setting of VA-ECMO support. In such patients, promoting forward blood flow across the prosthesis and improving levels of anticoagulation may be particularly important.
},
year = {2024}
}
TY - JOUR T1 - Thrombosis of Prosthetic Tricuspid Valve During Veno-Arterial Extracorporeal Membrane Oxygenation Support: A Case Report AU - Yunyi Zhang AU - Shuhua Luo Y1 - 2024/02/20 PY - 2024 N1 - https://doi.org/10.11648/j.ijacm.20241201.13 DO - 10.11648/j.ijacm.20241201.13 T2 - International Journal of Anesthesia and Clinical Medicine JF - International Journal of Anesthesia and Clinical Medicine JO - International Journal of Anesthesia and Clinical Medicine SP - 11 EP - 14 PB - Science Publishing Group SN - 2997-2698 UR - https://doi.org/10.11648/j.ijacm.20241201.13 AB - Extracorporeal membrane oxygenation (ECMO) is frequently used for severe postcardiotomy cardiogenic shock in patients with bioprosthetic valves. Acute prosthetic valve thrombosis (PVT) is a rare complication after valve replacement surgery and significantly increases morbidity and mortality. Patients who develop PVT on ECMO could significantly influence the long-term durability of the bioprosthetic valves. However, previous studies only analyzed risk factor and treatment of the mitral valve thrombosis during ECMO support. The mechanism of thrombosis on the tricuspid valve was still unknown. Here we describe the symptoms and treatment of a valve replacement patient who developed bioprosthetic tricuspid valve thrombosis during veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Meanwhile, the patient’s mechanical prosthetic mitral valve functioned normally. An emergency re-do tricuspid prosthesis replacement was performed, and the patient finally developed the successful decannulation. At 6 months follow-up, the patient showed asymptomatic and had a reasonable quality of life. The pathophysiology of tricuspid valve thrombosis may be different from the left heart. Our case highlights that the risk of thrombosis associated with a prosthesis in the tricuspid position can be even higher in the setting of VA-ECMO support. In such patients, promoting forward blood flow across the prosthesis and improving levels of anticoagulation may be particularly important. VL - 12 IS - 1 ER -
Department of Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu, China
